| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.005 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |